Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunityMark D Lacy, Jason D Maguire, Mazie J Barcus, et al.
The Lancet. Infectious Diseases|September 10, 2022
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studiesHelen S Marshall, Timo Vesikari, Peter C Richmond, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2008
Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparumRajeev K Mehlotra, Gabriel Mattera, Moses J Bockarie, et al.
Anesthesiology|March 19, 2025
Inhibition of Endoplasmic Reticulum Oxidoreductin 1 Modulates Neuronal Excitability and Nociceptive Sensitivity in MiceAislinn D Maguire, Shawn M Lamothe, Muhammad Saad Yousuf, et al.
Vaccine|July 3, 2021
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 monthsLars Østergaard, Timo Vesikari, Shelly D Senders, et al.
Vaccine|March 4, 2000
Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteersT P Le, K M Coonan, R C Hedstrom, et al.
The Lancet. Child & Adolescent Health|June 18, 2026
Immunogenicity and safety of a pentavalent meningococcal MenABCWY vaccine in healthy adolescents and young adults: a phase 3, multicountry, randomised, observer-blinded, active-controlled non-inferiority trialLars Ostergaard, Hanna Czajka, Lilia Roque-Guerrero, et al.
Annals of Tropical Medicine and Parasitology|January 23, 2003
Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, IndonesiaJ D Maguire, M D Lacy, Sururi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2001
Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, IndonesiaJ K Baird, M D Lacy, H Basri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2002
Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, IndonesiaJudith Ling, J Kevin Baird, David J Fryauff, et al.
Pageof 16